Participants 80 142 5
human immunodeficiency virus-infected children and adolescents
Participants 343 395 4
human immunodeficiency virus (HIV)-infected children
Participants 643 770 7
Forty-one children and youths between 5 months and 21 years with prior NRTI and no prior NNRTI or protease inhibitor experience
Participants 2422 2454 4
HIV-infected children and adults
